Finance

Lists
BBNX:NASDAQ
Beta Bionics Inc
17,63 US$
+1,15%
(+0,20) 1D
17,63 US$
0,00% (0,00)
After hours
Closed: 9 ოქტ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BBNX...
Open
17,47 US$
High
17,88 US$
Low
17,12 US$
Mkt. cap
927,93 მლნ.
Avg. vol.
1,32 მლნ.
Volume
955,12 ათ.
52-wk high
32,71 US$
52-wk low
8,80 US$
EPS
-1,65 US$
Shares outstanding
52,64 მლნ.
No. of employees
422
Open
17,47 US$
High
17,88 US$
Low
17,12 US$
Mkt. cap
927,93 მლნ.
Avg. vol.
1,32 მლნ.
Volume
955,12 ათ.
52-wk high
32,71 US$
52-wk low
8,80 US$
EPS
-1,65 US$
Shares outstanding
52,64 მლნ.
No. of employees
422
News stories
From web sources and news partners
About Beta Bionics Inc
CEO-
Employees422
Founded2015
Headquartersირვაინი, კალიფორნია, ამერიკის შეერთებული შტატები
SectorMedical device
Websitebetabionics.com
Analyst ratings
Based on 14 analysts giving stock ratings to BBNX in the past 3 months
Buy
Buy
10
Hold
4
Sell
0
12-month forecast
Based on 14 Wall Street analysts offering 12 month price targets for BBNX in the last 3 months.
Highest
Current 17,63 US$
30,40 US$ (+72,43%)
Average
23,72 US$ (+34,54%)
Lowest
16,00 US$ (-9,25%)
Analyst
Recommendation
Action
Price target
Projected
Date
Christopher Pasquale
Barclays
Buy
Initiated
30,00 US$
+70,2%
10/06/2026
Unknown Analyst
Barclays
Buy
Initiated
30,00 US$
+70,2%
10/06/2026
Richard Newitter
Truist Financial
Buy
Reiterated
28,00 US$
+58,8%
09/24/2026
Larry Biegelsen
Wells Fargo
Buy
Initiated
28,00 US$
+58,8%
09/23/2026
Frank Takkinen
Lake Street
Buy
Reiterated
25,00 US$
+41,8%
09/22/2026
Mike Kratky
Leerink Partners
Buy
Reiterated
27,00 US$
+53,1%
09/17/2026
Jonathan Block
Stifel Nicolaus
Buy
Maintained
22,00 US$
+24,8%
09/15/2026
Jeff Johnson
Robert W. Baird
Hold
Maintained
16,00 US$
-9,2%
09/15/2026
Patrick Wood
UBS
Buy
Maintained
25,00 US$
+41,8%
09/15/2026
Travis Steed
Bank of America Securities
Hold
Reiterated
20,00 US$
+13,4%
09/14/2026
Mathew Blackman
TD Cowen
Hold
Maintained
18,00 US$
+2,1%
09/14/2026
Steven Lichtman
William Blair
Hold
Maintained
-
-
09/14/2026
Jeffrey Cohen
Ladenburg Thalmann & Co.
Buy
Reiterated
30,40 US$
+72,4%
07/30/2026
Matthew O'Brien
Piper Sandler
Buy
Reiterated
20,00 US$
+13,4%
07/30/2026
Danielle Antalffy
UBS
Buy
Initiated
22,00 US$
+24,8%
07/28/2026
David Roman
Goldman Sachs
Buy
Reiterated
19,00 US$
+7,8%
07/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
27,25 მლნ.
32,12 მლნ.
27,63 მლნ.
32,01 მლნ.
Cost of goods sold
12,13 მლნ.
13,18 მლნ.
11,19 მლნ.
13,11 მლნ.
Cost of revenue
12,13 მლნ.
13,18 მლნ.
11,19 მლნ.
13,11 მლნ.
Research and development expenses
8,20 მლნ.
10,13 მლნ.
10,36 მლნ.
10,24 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
23,97 მლნ.
24,94 მლნ.
30,35 მლნ.
34,24 მლნ.
Operating expense
32,16 მლნ.
35,07 მლნ.
40,71 მლნ.
44,48 მლნ.
Total operating expenses
44,30 მლნ.
48,24 მლნ.
51,90 მლნ.
57,59 მლნ.
Operating income
-17,04 მლნ.
-16,12 მლნ.
-24,27 მლნ.
-25,58 მლნ.
Other non operating income
1,00 ათ.
-
-
-2,00 ათ.
EBT including unusual items
-14,21 მლნ.
-13,47 მლნ.
-21,90 მლნ.
-23,40 მლნ.
EBT excluding unusual items
-14,21 მლნ.
-13,47 მლნ.
-21,90 მლნ.
-23,40 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-14,21 მლნ.
-13,47 მლნ.
-21,90 მლნ.
-23,40 მლნ.
Net profit margin
-52,14%
-41,92%
-79,25%
-73,10%
Earnings per share
-0,33
-0,19
-0,36
-0,36
Interest and investment income
2,83 მლნ.
2,66 მლნ.
2,38 მლნ.
2,18 მლნ.
Interest expense
-
-
-
-
Net interest expenses
2,83 მლნ.
2,66 მლნ.
2,38 მლნ.
2,18 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-16,66 მლნ.
-15,59 მლნ.
-23,69 მლნ.
-24,87 მლნ.
Gain or loss from assets sale
-
31,00 ათ.
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები